GITSX
Price
$29.02
Change
+$0.14 (+0.48%)
Updated
Jul 25 closing price
Net Assets
913.65M
SCMIX
Price
$164.85
Change
+$0.49 (+0.30%)
Updated
Jul 25 closing price
Net Assets
15.09B
Interact to see
Advertisement

GITSX vs SCMIX

Header iconGITSX vs SCMIX Comparison
Open Charts GITSX vs SCMIXBanner chart's image
Goldman Sachs Technology Opps Svc
Price$29.02
Change+$0.14 (+0.48%)
VolumeN/A
Net Assets913.65M
Columbia Seligman Tech & Info Inst2
Price$164.85
Change+$0.49 (+0.30%)
VolumeN/A
Net Assets15.09B
GITSX vs SCMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GITSX vs. SCMIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GITSX is a Buy and SCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCMIX has more cash in the bank: 15.1B vs. GITSX (914M). GITSX (0.00) and SCMIX (0.00) have matching dividends . GITSX was incepted earlier than SCMIX: GITSX (26 years) vs SCMIX (24 years). GITSX (1.53) is less costly to investors than SCMIX (0.89). SCMIX is a more actively managed with annual turnover of: 39.00 vs. GITSX (37.00). GITSX (0) and SCMIX (0) have matching initial minimum investment requirements. GITSX annual gain was more profitable for investors over the last year : 23.44 vs. SCMIX (12.13). SCMIX return over 5 years is better than : 69.95 vs. GITSX (14.43).
GITSXSCMIXGITSX / SCMIX
Total Expense Ratio1.390.89156%
Annual Report Gross Expense Ratio1.530.89172%
Fund Existence26 years24 years-
Gain YTD11.23010.142111%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets914M15.1B6%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.4412.13193%
Returns for 3 years53.2247.90111%
Returns for 5 years14.4369.9521%
Returns for 10 years53.54159.1234%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKTX1.120.02
+1.82%
Akari Therapeutics plc
DRTS3.060.04
+1.32%
Alpha Tau Medical Ltd
SLGN55.720.35
+0.63%
Silgan Holdings
SMFG16.23-0.01
-0.06%
Sumitomo Mitsui Financial Group
NRP100.16-1.28
-1.26%
Natural Resource Partners LP